<DOC>
	<DOCNO>NCT02223442</DOCNO>
	<brief_summary>Chronic pain define pain persists heal wound cause , occur even absence obvious pathological trigger . In country , grow interest proper management disease `` pain '' . Pain also first symptom disease 20 -50 % patient neoplastic disease 75 % 90 % patient advanced cancer suffers chronic pain . However , pain management mostly inadequate . This study aim assess Italian clinical practice reference pharmacological management chronic pain health professional involve treatment pain center belong Italian network pain therapy .</brief_summary>
	<brief_title>Central Analgesic Drugs Treatment Chronic Pain</brief_title>
	<detailed_description>Chronic pain define pain persists heal wound cause , occur even absence obvious pathological trigger . In country , grow interest proper management disease `` pain '' . In fact , Ministry Health , first Europe , introduce law 2010 ( March 15 , 2010 , No . 38 ) provide sick , cancer , easy access necessary care provide specialist specific train course . Pain also first symptom disease 20 -50 % patient neoplastic disease 75 % 90 % patient advanced cancer suffers chronic pain ( Marcus 2011 ) . The `` pain disease '' one common cause access medical care recognize complex health research problem , one expensive investigated condition society ( Pizzo Clark , 2012 ; Gupta et al . , 2010 ; Dagenais et al. , 2008 ) . It significant impact subjective perception health status , influence daily activity associate symptom depression psychological problem affect quality life patient ( end 2011 Gureje et al. , 1998 ; Bair et al. , 2003 , Portenoy , 1996 ) . However , pain management mostly inadequate several medical social reason : difficulty define complexity pathophysiology , difficulty find animal model useful development analgesic drug , difficulty find clinical model predictive drug efficacy / security , lack recognition pain health issue adequate academic training . A recent survey Europe uncover alarm data : 40 % survey patient ( 46,394 ) report inadequate treatment accuse pain ( Breivik et al. , 2006 ) . There also several open question regard research powerful analgesic drug use : opioids ( Galer et al 1992 ) . There specific experimental model able solve three press problem : predictability patient 's response , efficacy safety opioids . There scientific evidence efficacy / safety long-term use opioids chronic pain ( Chapman et al. , 2010 ; Manchikanti et al. , 2011 ) . A recent review show approximately 22 % patient , suffer chronic pain opioid therapy , suspend therapy occurrence side effect 5-10 % patient suspend proper control pain symptom ( Noble et al. , 2010 ) . This study aim assess Italian clinical practice reference pharmacological management chronic pain health professional involve treatment pain center belong Italian network pain therapy .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Males female age 18 year Chronic neuropathic / nociceptive / mixed pain , whereby clinician considers necessary start opioid therapy Signed informed consent Males females age 18 year Patients already receive opioid analgesic drug drug class MORNRI . Taking abuse drug alcohol abuse Patients contraindication use central analgesic drug Patients refuse participation Prior cognitive impairment mental retardation Severe immunodeficiency ( WBC &lt; 4,000 ) Severe renal impairment ( serum creatinine &gt; 2g/dl Creatinine clearance &lt; 30 ml / h ) Hepatic impairment ( Cholinesterase &lt; 2.000UI INR &gt; 2 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>central analgesic drug</keyword>
	<keyword>adherence therapy</keyword>
	<keyword>side effect</keyword>
	<keyword>quality life</keyword>
	<keyword>MOR-NRI drug</keyword>
</DOC>